Abstract:This two‐part study included consensus‐building surveys and a cross‐sectional survey among participants with self‐reported dermatological conditions to assess instrument psychometric properties of the revised Internalized Skin Bias Questionnaire (ISBQ‐R). Overall, 33 experts participated including 22 (66.7%) dermatologists or dermatology researchers and 11 (33.3%) patients. The revised survey was completed by 214 participants with various dermatological conditions. Adding and modifying new items (9 in total) resulted in an instrument with stronger internal consistency (Cronbach's alpha = 0.92) and a stronger correlation with other existing stigma measures (ρ = 0.72) as well as health‐related quality of life (ρ = −0.68), anxious (ρ = 0.51) and depressive (0.53) symptoms. Additionally, the study further expanded upon previous research by exploring a two‐factor structure, suggesting that the ISBQ‐R could be used as a single or dual factor instrument depending on investigator goals. Background The psychological impacts of skin disease are well documented, with patients reporting increased anxiety, depression and poorer quality of life. More recent studies suggest that adverse psychopathology is associated with re‐direction of skin‐disease‐related social stigma towards oneself or internalized skin bias (ISB). Objectives To refine the Internalized Skin Bias Questionnaire (ISBQ) to reflect the construct of ISB with additional skin‐specific biases as well as to evaluate its psychometric properties in a diverse sample of individuals with various skin conditions. Methods Two‐part observational design including consensus‐building surveys among a dermatology expert group and a cross‐sectional survey among participants with self‐reported dermatological conditions to assess instrument psychometric properties. Eligible participants completed an online survey comprised of the revised ISBQ (ISBQ‐R), the Questionnaire on Experiences with Skin Diseases‐Short Form (QES‐SF), the Dermatology Life Quality Index (DLQI), the Beck Depression Inventory‐II (BDI‐II) and the Burns Anxiety Inventory (BAI). Results Overall, 33 experts participated including 22 (66.7%) dermatologists or dermatology researchers and 11 (33.3%) patients. Except for three items in the first round, all items received high agreement for inclusion from the expert group. The revised survey was completed by 214 participants who identified mostly as female (n = 185; 86.9%), White (n = 182; 85.5%) and non‐Hispanic/Latino (n = 200; 93.4%). Adding and modifying new items resulted in an instrument with stronger internal consistency (Cronbach's alpha = 0.92) and a stronger correlation with other existing stigma measures (QES‐SF; ρ = 0.72). Conclusions The ISBQ‐R is a modified instrument with stronger internal consistency and a stronger correlation with other existing stigma measures. Additionally, the study further expanded upon previous research by exploring a two‐factor structure, suggesting that the ISBQ‐R could be used as a single‐ or a dual‐factor instrument depending on investigator goals.

Internalized Stigma and Its Relationship With Quality of Life and Perceived Health Status in Rosacea and Acne Vulgaris: A Comparative Cross-Sectional Study

Relationship of interoceptive accuracy in acne vulgaris patients: A prospective, controlled study

The Implication of Misinformation and Stigma in Age-Related Quality of Life, Depression, and Coping Mechanisms of Adult Patients with Psoriasis

Health-related Quality of Life of Patients with Rosacea: A Systematic Review and Meta-analysis of Real-world Data

Alexithymia in Adolescents with Acne: Association with Quality of Life Impairment and Stigmatization

Evaluation of Stigma Toward Individuals With Acne

Stigmatization and social ostracism of patients with psoriasis: a qualitative phenomenological study

Correlation of internalized stigma with self-esteem, social support and coping styles in patients with rheumatoid arthritis: A cross-sectional study

Evaluation of social anxiety, self-esteem, life quality in adolescents with acne vulgaris

The association of depression, loneliness and internet addiction levels in patients with acne vulgaris

Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa

Stigmatization in Patients With Psoriasis: A Mini Review

Stigmatization and Quality of Life in Patients with Psoriasis

The Dermatology Life Quality Index (DLQI) and the Hospital Anxiety and Depression (HADS) in Chinese Rosacea Patients.

Psychometric properties of the revised internalized skin bias questionnaire

Evaluation of Thiol Disulfide Homeostasis and Ischemia-Modified Albumin Levels as an Indicator of Oxidative Stress in Acne Vulgaris

Study on the Impact of Psoriasis on Quality of Life: Psychological, Social and Financial Implications

Internalised Stigma, Self-Esteem and Perceived Social Support as Psychosocial Predictors of Quality of Life in Adult Patients with Schizophrenia

Quality of life, sleep and anxiety status among patients with rosacea in the Yunnan plateau region: A 2‐year retrospective study

Internalized stigma level, family self-stigma, and family burden of patients receiving community mental health center services: a comparative, longitudinal study

Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China